NL-OMON37018
Completed
Phase 3
Paracetamol intravenously in neonates with a gestational age of less than 32 weeks - PIN32
Maxima Medisch Centrum0 sites15 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- nociceptie
- Sponsor
- Maxima Medisch Centrum
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Gestational age less than 32 weeks
- •Analgesia indicated as per pain protocol
- •Indwelling arterial catheter available
- •Informed consent
Exclusion Criteria
- •Co\-medication: analgesia, sedatives, muscle relaxants, phenobarbital
- •Asphyxiated patients
- •Signs of liver failure prior to inclusion
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Paracetamol, administered directly into a vein in babies born after a pregnancy of less than 32 weeksEUCTR2010-019678-34-NL
Active, not recruiting
Phase 1
Safety of paracetamol in neonatesLiver toxicity following prolonged administration of i.v. or oral paracetamolMedDRA version: 20.1 Level: LLT Classification code 10019850 Term: Hepatotoxic effect System Organ Class: 100000004871Therapeutic area: Not possible to specifyEUCTR2017-002724-25-DKHelle Holst120
Active, not recruiting
Phase 1
Extremely low gestational age infants' PARAcetamol StudyOpen ductus arteriosus of a premature infantTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]EUCTR2018-000566-11-FIniversity of Oulu40
Active, not recruiting
Not Applicable
Pain treatment of newborns: paracetamol rectal versus intraveneous administration, an open randomised clinical trial. - Pain treatment of newborns: paracetamol rectal versus intraveneous administration.EUCTR2009-011753-41-NLeonatal intensive care unit, VU medical center Amsterdam
Completed
Phase 2
Pain treatment of newborns: paracetamol rectal versus intraveneous administration, an open randomised clinical trial.pijnpainsufferNL-OMON35587Vrije Universiteit Medisch Centrum24